TESTING THE SAFETY AND EFFICACY OF CARG-201, AN RNA REPLICON-BASED THERAPEUTIC VACCINE FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS

Carogen Corp

Investigators